このアイテムのアクセス数: 125

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
j.reth.2019.06.008.pdf1.53 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorMomotori, Naokien
dc.contributor.authorJo, Jun ichiroen
dc.contributor.authorTabata, Yasuhikoen
dc.contributor.alternative城, 潤一郎ja
dc.contributor.alternative田畑, 泰彦ja
dc.date.accessioned2020-02-03T05:03:16Z-
dc.date.available2020-02-03T05:03:16Z-
dc.date.issued2019-12-01-
dc.identifier.issn2352-3204-
dc.identifier.urihttp://hdl.handle.net/2433/245559-
dc.description.abstractIntroduction: Macrophages play an important role in regulating inflammation and tissue regeneration. It is known that anti-inflammatory macrophages play an important role for tissue regeneration. The objective of this study is to modify macrophages phenotypes for anti-inflammatory function by utilizing drug delivery technology. Method: In this study, 4 types of poly (L-lactic-co-glycolic acid) (PLGA) microspheres incorporating pioglitazone of an anti-inflammatory modifier (pio-MS) with different sizes were prepared. In vitro release test of pio-MS was performed in phosphate buffered-saline solution (PBS) containing 1 wt% of sodium lauryl sulfate. The arginase activity and the secretion of interleukin (IL)−10 as anti-inflammatory macrophage markers of mouse bone marrow derived-macrophages (BMDM) cultured with the pio-MS were evaluated. Results: The sustained release of pioglitazone was observed from all types of pio-MS in vitro. When BMDM were cultured with the pio-MS with an average diameter of 40 μm (pio-MS40), the arginase activity and the secretion of IL-10 increased to a significant extent compared with other pio-MS. Conclusions: The pio-MS40 with an diameter of 40 μm had a potential to induce the anti-inflammatory modification of BMDM in this culture system. The sustained release of pioglitazone is promoting to modify the macrophage function.en
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier BVen
dc.rights© 2019, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).en
dc.subjectMacrophagesen
dc.subjectPioglitazoneen
dc.subjectDrug delivery systemen
dc.subjectPoly(L-lactic-co-glycolic acid)en
dc.subjectPLGAen
dc.subjectMicrospheresen
dc.titlePreparation of polymer microspheres capable for pioglitazone release to modify macrophages functionen
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleRegenerative Therapyen
dc.identifier.volume11-
dc.identifier.spage131-
dc.identifier.epage138-
dc.relation.doi10.1016/j.reth.2019.06.008-
dc.textversionpublisher-
dc.addressLaboratory of Biomaterials, Institute for Frontier Life and Medical Sciences, Kyoto Universityen
dc.addressLaboratory of Biomaterials, Institute for Frontier Life and Medical Sciences, Kyoto Universityen
dc.addressLaboratory of Biomaterials, Institute for Frontier Life and Medical Sciences, Kyoto Universityen
dc.identifier.pmid31338392-
dcterms.accessRightsopen access-
dc.identifier.eissn2352-3204-
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。